Edgewise Therapeutics Statistics
NASDAQ: EWTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
39.57-0.45 (-1.12%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Edgewise Therapeutics by the numbers
Edgewise Therapeutics has a market capitalization of $4.30 billion based on 108.60M shares outstanding. With trailing EPS of $-1.84, Edgewise Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.6% below its 50-day average and 13.1% above its 200-day average.
Average daily trading volume is 1.35M shares, or about $53.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EWTX valuation vs. peer median
| Metric | EWTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.30B | $4.21B | +2% |
| Avg. volume | 1.35M | 2.22M | -39% |
Peer median across 8 companies: INDV, ABCL, MANE, DNTH, TLX, ERAS, LEGN, TNGX.
Valuation
- Market cap
- $4.30B
- EPS (TTM)
- $-1.84
- Shares outstanding
- 108.60M
Price and trading
- Previous close
- 40.02
- Open
- 39.66
- Day range
- 39.40 – 41.06
- 52-week range
- 14.25 – 48.51
- 52-week change
- +161.36%
- Beta
- —
- Volume
- 1.19M
- Average volume
- 1.35M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 4.30B
- Forward Pe
- -21.79
- Eps
- -1.84
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 48.51
- Week52 Low
- 14.25
- Avg Volume
- 1.35M
- Shares Outstanding
- 108.60M
- Ma50
- 42.83
- Ma200
- 34.98
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -18.43%
- Pct From52w Low
- 177.68%